About Us
Shaping the future of autoimmune testing.
We’re a global market leader in autoimmune diagnostics, delivering highly accurate reagents and highly efficient automation to labs throughout the world.
News
disease areas
Improving diagnostic accuracy.
Improving diagnostic accuracy.
To help improve the diagnosis of APS, we’ve introduced QUANTA Lite® PS/PT. This new assay is designed to increase the sensitivity in the diagnosis of APS without sacrificing specificity. It can help confirm a diagnosis even when a patient has already started anti-coagulation treatment. When used in combination with other markers, it offers insights for risk assessment related to thrombotic events and recurring pregnancy loss.
HIGHLIGHTS
- Improved patient care.Patients need not interrupt anticoagulation therapy for an accurate diagnosis of APS.
- Aid in clinical assessments.QUANTA Lite PS/PT assays deliver optimal results when used in combination with other QUANTA Lite APS tests – helping physicians diagnose APS quickly and confidently.
Reagents
Description
Package Size
Part Number
Lot number
Documents
Description
Package Size
Part Number
Lot number
Documents
*Only available outside of the US
**For Sale in the USA ONLY
**For Sale in the USA ONLY
Related Systems
QUANTA-Lyser® 3000
QUANTA-Lyser® 3000
QUANTA-Lyser 3000 is a high throughput EIA/IFA that give you the ability to complete your workload faster with less hands-on time.
QUANTA-Lyser® 160/240 EIA/IFA Processors
QUANTA-Lyser® 160/240 EIA/IFA Processors
Flexible EIA/IFA processing platform to meet the volume requirements of your laboratory
QUANTA-Lyser® 2
QUANTA-Lyser® 2
QUANTA-Lyser® 2 is the ideal platform for esoteric assays or in settings that require maximum flexibility and efficiency
BIO-FLASH®
BIO-FLASH®
Autoimmune chemiluminescent (CIA) analyzer eliminates batching and provides precise quantification.
**For Sale in the USA ONLY